Opportunity Information: Apply for RFA CK 25 035
The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement funding opportunity titled "Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya" (Funding Opportunity Number: RFA CK 25 035; CFDA: 93.326). The overall aim is to strengthen malaria control and prevention efforts in Kenya by supporting applied research and practical public health work that directly informs implementation. The focus is on malaria operations research, surveillance, and monitoring and evaluation (M and E), with the expectation that funded activities will generate findings that can improve program strategies, reduce malaria burden, and improve health outcomes for communities most affected by malaria.
This opportunity is designed around implementation-focused learning: it funds studies and evaluations that help decision-makers understand what is working, what is not, and how to optimize malaria interventions in real-world settings. That includes generating evidence on the performance and impact of malaria control and prevention tools, improving the use of surveillance data for program decisions, and evaluating operational approaches that could increase coverage, quality, and effectiveness of malaria services. Because the funding instrument is a cooperative agreement, applicants should anticipate substantial CDC involvement during the project period, such as technical input, collaboration on evaluation design and analytic approaches, and alignment with broader malaria control priorities.
Eligibility is broad in terms of organization type. Applicants may include various levels of government (state, county, city/township, special districts), eligible tribal governments and organizations, public housing authorities, nonprofit organizations (with or without 501(c)(3) status), public and private institutions of higher education, and for-profit organizations (other than small businesses), as well as other entities. Foreign organizations and institutions are explicitly eligible to apply, which is notable given the Kenya-based scope and implementation needs.
At the same time, eligibility includes a specific Kenya-centered requirement tied to operational capacity and partnership. To be considered eligible, an applicant must demonstrate a presence in Western Kenya and provide evidence of prior malaria research conducted in collaboration with the Kenya Medical Research Institute (KEMRI) Center for Global Health Research. The application must also include a letter of support and collaboration from the KEMRI Center for Global Health Research Malaria Program director confirming their intention to collaborate on the proposed project. In practical terms, this means successful applicants will need to show not only technical expertise in malaria research and evaluation, but also established, credible working relationships and on-the-ground ability to carry out surveillance, operations research, and M and E activities in the region.
The CDC expects to make one award under this announcement. The award ceiling is $3,000,000. The notice was created on November 25, 2024, and the original application closing date is February 12, 2025. The sponsoring agency is the Centers for Disease Control and Prevention (CDC), listed as CDC - ERA. Overall, the opportunity is structured to fund a single, high-impact partnership that can produce actionable evidence to improve malaria program implementation in Kenya, particularly by leveraging strong collaboration with KEMRI and established operational presence in Western Kenya.Apply for RFA CK 25 035
- The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.326.
- This funding opportunity was created on 2024-11-25.
- Applicants must submit their applications by 2025-02-12. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the title of this CDC funding opportunity?
The title is "Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya."
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA CK 25 035.
3) What is the CFDA number listed for this opportunity?
The CFDA number is 93.326.
4) Which agency is sponsoring this opportunity?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC), listed as CDC - ERA.
5) What type of funding mechanism is being used?
This opportunity is a cooperative agreement, which means CDC expects to have substantial involvement during the project period.
6) What does "substantial CDC involvement" mean in this cooperative agreement?
Based on the description provided, applicants should expect CDC involvement such as technical input, collaboration on evaluation design and analytic approaches, and alignment with broader malaria control priorities during implementation.
7) What is the overall aim of the opportunity?
The overall aim is to strengthen malaria control and prevention efforts in Kenya by supporting applied research and practical public health work that directly informs implementation.
8) What are the main focus areas of the funded work?
The focus areas are malaria operations research, surveillance, and monitoring and evaluation (M and E).
9) What kind of results is CDC expecting from funded activities?
Funded activities are expected to generate findings that can improve program strategies, reduce malaria burden, and improve health outcomes for communities most affected by malaria.
10) What does "implementation-focused learning" mean in the context of this opportunity?
It refers to funding studies and evaluations that help decision-makers understand what is working, what is not, and how to optimize malaria interventions in real-world settings.
11) What kinds of projects or activities fit this opportunity based on the description?
Examples described include studies and evaluations that generate evidence on the performance and impact of malaria control and prevention tools, improve the use of surveillance data for program decisions, and evaluate operational approaches to increase coverage, quality, and effectiveness of malaria services.
12) Where is the work expected to be based?
The scope and implementation needs are Kenya-based, and the eligibility requirements specifically reference having a presence in Western Kenya.
13) Who is eligible to apply in terms of organization type?
Eligibility is broad and includes various levels of government (state, county, city/township, special districts), eligible tribal governments and organizations, public housing authorities, nonprofit organizations (with or without 501(c)(3) status), public and private institutions of higher education, for-profit organizations (other than small businesses), and other entities.
14) Are foreign organizations eligible to apply?
Yes. Foreign organizations and institutions are explicitly eligible to apply.
15) Are for-profit organizations allowed to apply?
Yes. For-profit organizations are eligible as stated, but small businesses are excluded ("other than small businesses").
16) Is there a Kenya-specific eligibility requirement beyond organization type?
Yes. To be considered eligible, an applicant must demonstrate a presence in Western Kenya and provide evidence of prior malaria research conducted in collaboration with the Kenya Medical Research Institute (KEMRI) Center for Global Health Research.
17) What role does KEMRI play in eligibility?
KEMRI partnership is a stated eligibility requirement. The applicant must show prior malaria research conducted in collaboration with the KEMRI Center for Global Health Research.
18) Is a letter of support required from KEMRI?
Yes. The application must include a letter of support and collaboration from the KEMRI Center for Global Health Research Malaria Program director confirming their intention to collaborate on the proposed project.
19) What must the KEMRI letter confirm?
It must confirm the intention to collaborate on the proposed project, and it must come from the KEMRI Center for Global Health Research Malaria Program director.
20) What does it mean to "demonstrate a presence in Western Kenya"?
The opportunity states that applicants must demonstrate a presence in Western Kenya as part of eligibility. The specific form of documentation is not detailed in the provided information.
21) How many awards does CDC expect to make?
CDC expects to make one award under this announcement.
22) What is the maximum award amount (award ceiling)?
The award ceiling is $3,000,000.
23) When was the notice created?
The notice was created on November 25, 2024.
24) What is the application closing date?
The original application closing date is February 12, 2025.
25) What is the intended impact of funding a single award?
The opportunity is structured to fund a single, high-impact partnership that can produce actionable evidence to improve malaria program implementation in Kenya, leveraging strong collaboration with KEMRI and an established operational presence in Western Kenya.
26) What kinds of improvements to malaria programs are emphasized?
The description emphasizes improving program strategies, reducing malaria burden, improving health outcomes, improving the use of surveillance data for program decisions, and optimizing operational approaches to increase coverage, quality, and effectiveness of malaria services.
27) Does this opportunity emphasize research only, or also practical public health work?
It emphasizes both: applied research and practical public health work that directly informs implementation.
28) What geographic area within Kenya is specifically highlighted?
Western Kenya is specifically highlighted through the eligibility requirement to demonstrate presence there.
29) What does the opportunity suggest about partnership expectations?
It indicates that successful applicants will need established, credible working relationships (particularly with KEMRI) and on-the-ground ability to carry out surveillance, operations research, and M and E activities in Western Kenya.
30) What is the primary use of the evidence generated by funded activities?
The primary purpose is to produce actionable findings that directly inform implementation and help decision-makers optimize malaria interventions in real-world settings.
Browse more opportunities from the same category: Health
Next opportunity: Public Wireless Supply Chain Innovation Fund Grant Program - Software Solutions for Industry Verticals and Integration Automation
Previous opportunity: Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 25 035
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 25 035) also looked into and applied for these:
| Funding Opportunity |
|---|
| Changing Health Systems Using Evidence-based interventions to increase Colorectal Cancer Screening Apply for CDC RFA DP 25 0012 Funding Number: CDC RFA DP 25 0012 Agency: Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $900,000 |
| Innovative Approaches for TB Prevention and Case Finding to END TB Apply for RFA JG 25 137 Funding Number: RFA JG 25 137 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $2,000,000 |
| Tribal Self-Governance Negotiation Cooperative Agreement Program Apply for HHS 2025 IHS TSGN 0001 Funding Number: HHS 2025 IHS TSGN 0001 Agency: Indian Health Service Category: Health Funding Amount: $84,000 |
| Tribal Self-Governance Planning Cooperative Agreement Program Apply for HHS 2025 IHS TSGP 0001 Funding Number: HHS 2025 IHS TSGP 0001 Agency: Indian Health Service Category: Health Funding Amount: $180,000 |
| Tribal Management Grant Program Apply for HHS 2025 IHS TMD 0001 Funding Number: HHS 2025 IHS TMD 0001 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| Supporting sustainable, accessible, integrated and quality laboratory systems for HIV/TB and related health threats in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA JG 25 0164 Funding Number: CDC RFA JG 25 0164 Agency: Centers for Disease Control-GHC Category: Health Funding Amount: Case Dependent |
| Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 25 126 Funding Number: RFA DP 25 126 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $5,902,000 |
| NIOSH Underground Mine Evacuation Technologies and Human Factors Research Apply for RFA OH 25 183 Funding Number: RFA OH 25 183 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $3,000,000 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 052 Funding Number: PAR 25 052 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAS 25 190 Funding Number: PAS 25 190 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) Apply for PAR 25 035 Funding Number: PAR 25 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 034 Funding Number: PAR 25 034 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 25 267 Funding Number: PAR 25 267 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) Apply for PAR 25 268 Funding Number: PAR 25 268 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed) Apply for PAR 24 290 Funding Number: PAR 24 290 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) Apply for PAR 25 287 Funding Number: PAR 25 287 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) Apply for PAR 25 286 Funding Number: PAR 25 286 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Apply for PAR 25 274 Funding Number: PAR 25 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required) Apply for RFA RM 24 008 Funding Number: RFA RM 24 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 24 076 Funding Number: RFA AI 24 076 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 25 035", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.